BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 30341970)

  • 21. Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Ando T; Akintoye E; Telila T; Briasoulis A; Takagi H; Schreiber T; Afonso L; Grines CL
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):813-819. PubMed ID: 28990736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Outcomes with Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials.
    Kundu A; Sardar P; Malhotra R; Qureshi WT; Kakouros N
    Cardiovasc Revasc Med; 2020 Apr; 21(4):453-460. PubMed ID: 31669113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population.
    Barbanti M; Tamburino C; D'Errigo P; Biancari F; Ranucci M; Rosato S; Santoro G; Fusco D; Seccareccia F;
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007825. PubMed ID: 31284737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal Trends and Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis.
    Elbadawi A; Saad M; Elgendy IY; Barssoum K; Omer MA; Soliman A; Almahmoud MF; Ogunbayo GO; Mentias A; Gilani S; Jneid H; Aronow HD; Kleiman N; Abbott JD
    JACC Cardiovasc Interv; 2019 Sep; 12(18):1811-1822. PubMed ID: 31537280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of Patients with Low-Gradient Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement.
    Kugelman N; Jaffe R; Aronson D; Sharoni E; Adawi S; Khader N; Shiran A
    Cardiovasc Revasc Med; 2020 Mar; 21(3):257-262. PubMed ID: 31103371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing Wait-Time Mortality for Severe Aortic Stenosis: A Population-Level Study of the Transition in Practice From Surgical Aortic Valve Replacement to Transcatheter Aortic Valve Replacement.
    Albassam O; Henning KA; Qiu F; Cram P; Sheth TN; Ko DT; Woodward G; Austin PC; Wijeysundera HC
    Circ Cardiovasc Interv; 2020 Nov; 13(11):e009297. PubMed ID: 33167700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Sardar P; Kundu A; Chatterjee S; Feldman DN; Owan T; Kakouros N; Nairooz R; Pape LA; Feldman T; Dawn Abbott J; Elmariah S
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):504-515. PubMed ID: 28398671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Condado JF; Maini A; Leshnower B; Thourani V; Forcillo J; Devireddy C; Mavromatis K; Sarin EL; Stewart J; Guyton R; Simone A; Keegan P; Lerakis S; Block PC; Babaliaros V
    Catheter Cardiovasc Interv; 2017 May; 89(6):1109-1115. PubMed ID: 28211605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
    Elgendy IY; Mahmoud AN; Elbadawi A; Elgendy AY; Omer MA; Megaly M; Mojadidi MK; Jneid H
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):989-995. PubMed ID: 30569661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease.
    Khan MZ; Khan MU; Kalra A; Krupica T; Kaluski E; Khan SU
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1102-1109. PubMed ID: 33034959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Alkhalil A; Golbari S; Song D; Lamba H; Fares A; Alaiti A; Deo S; Attizzani GF; Ibrahim H; Ruiz CE
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):757-765. PubMed ID: 29171682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Arora S; Vaidya SR; Strassle PD; Misenheimer JA; Rhodes JA; Ramm CJ; Wheeler EN; Caranasos TG; Cavender MA; Vavalle JP
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):806-812. PubMed ID: 29068166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
    Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
    Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
    Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
    J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.
    Crestanello JA; Popma JJ; Adams DH; Deeb GM; Mumtaz M; George B; Huang J; Reardon MJ
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2283-2293. PubMed ID: 29102579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.